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Summary 
Hematopoietic stem cells  (HSC) are multipotent cells that reside in the bone marrow and re- 
plenish all adult hematopoietic hneages throughout the lifetime of the animal. While experi- 
menting with staining of murine bone marrow cells with the vital dye, Hoechst 33342, we dis- 
covered  that  display  of Hoechst  fluorescence  simultaneously  at  two  emission  wavelengths 
revealed a small and distinct subset of whole bone marrow ceils that had phenotypic markers of 
multipotential HSC. These cells were shown in competitive repopulation experiments to con- 
rain the vast majority of HSC activity from murine bone marrow and to be enriched at least 
1,000-fold for in vivo reconstitution  activity. Further,  these Hoechst-stained side population 
(SP) cells were shown to protect recipients from lethal irradiation at low cell doses, and to con- 
tribute to both lymphoid and myeloid lineages. The formation of the Hoechst SP profile was 
blocked when staining was performed in the  presence of verapamil, indicating that the  dis- 
tinctly low staining pattern of the  SP  cells  is due  to a multidrug resistance protein  (mdr)  or 
mdr-like mediated efflux of the dye from HSC. The ability to block the Hoechst efl]ux activity 
also allowed us to use Hoechst to determine the DNA content of the SP cells. Between 1 and 
3% of the HSC were shown to be in S-G2M. This also enabled the purification of the G0-G~ 
and S-G2M subsets of fresh purified HSC.  Transplantation of these subsets of HSC revealed 
that S-G2M HSC had a reconstitution capacity equivalent to quiescent stem cells.  These find- 
ings have implications for models of hematopoietic cell development and for the development 
of genetic therapies for diseases involving hematopoietic cells. 
H 
ematopoietic stem cells  (HSC) 1 are multipotent cells 
that  reside  in  the  bone  marrow and give rise  to  all 
adult hematopoietic lineages of mice. HSC are thought to 
be inherently quiescent, dividing little or not at all until re- 
quired to differentiate, yet capable of self-renewal. Proba- 
bly the best evidence in support of the self-renewal of stem 
cells comes from studies that have examined the recovery of 
mouse bone marrow after repeated ablation with cytotoxic 
agents  (1)  as  well  as  from retroviral  marking  studies  (2). 
Substantial evidence also exists that suggests that the capac- 
ity for self renewal of stem cells may be hrnited. Serial trans- 
plantation of either whole bone marrow or highly purified 
HSC results in a loss of multilineage reconstituting capacity 
(3-8). This loss of HSC function could be due to effects of 
the  transplantation  process itself, or to a lack of regenera- 
tion of HSC after proliferation. The inability to establish in 
1Abbreviations used in this paper: CFU-s(12), day 12 spleen colony-forming 
activity; HSC, hematopoietic  stem cell(s); mdr, multidrug resistance pro- 
tein; PI, propidium iodide; Rh123, 1Lhodamine-123; SP, side population. 
vitro culture conditions that result in the significant expan- 
sion of stem cells  able to engraft lethally irradiated recipi- 
ents may also indicate that the self-renewal capacity of stem 
cells is limited. 
ILesolution of the issue  of the capacity of HSC for self- 
renewal may be facilitated through an examination of the 
functional properties of HSC that have undergone a cycle 
of cell division. We sought to address this issue through the 
physical isolation of live HSC that were undergoing cell di- 
vision,  and by comparison of the  engraftment of the  cy- 
cling  cells  to  that  of quiescent  HSC  by long-term bone 
marrow transplantation  in mice. Toward this  end, we at- 
tempted  to  use  the  fluorescent vital dye  Hoechst  33342, 
which binds DNA in live cells, and is therefore an indicator 
of cell cycle as it relates to DNA content (9), to isolate rep- 
licating and quiescent cell populations. In prehminary stud- 
ies,  however,  we found that both unfractionated  and en- 
riched bone marrow populations yielded an uninterpretable 
DNA staining profile.  In the  course  of those  studies,  we 
observed a complex fluorescence pattern of Hoechst dye in 
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played  simultaneously at  two  emission wavelengths.  This 
led us  to  identify a  small subset  of Hoechst-staining cells 
that were well separated from the rest of the bone marrow, 
contained a majority of cells that had cell surface markers of 
HSC,  and were  enriched for HSC  activity at least  1,000- 
fold.  We  show  that  this  distinct  staining pattern  by  the 
HSC  is due to  a  high level of dye efl]ux activity that may 
be mediated by p-glycoprotein or a  related molecule. We 
have used this enrichment strategy and associated observa- 
tions to further develop a method to purify subsets of HSC 
that are in G0-G1 or in S-G2M and to show that these pop- 
ulations appear  to  have  equivalent abifities to  reconstitute 
the hematopoietic system of lethally irradiated recipients. 
Materials  and Methods 
Mouse Strains.  Mice  were  obtained at  5-8  wk  of age  and 
were used between 6 and 12 wk of age. C57BI/6 mice were ob- 
tained  from  The  Jackson  Laboratory  (Bar  Harbor,  ME),  and 
C57B1/6-Ly-5.1  mice were  obtained from the National Cancer 
Institute (Bethesda, MD). All mice were maintained on acidified 
water. 
Preparation of Bone Marrow Cells  for FACS  ~.  Murine bone mar- 
row was extracted from the femurs and tibias of C57B1/6 mice, a 
single cell suspension was made by passage  of the bone marrow 
through an 18-gauge needle, and the cells were pelleted by cen- 
trifugation. The bone marrow cells were resuspended at 106 cells 
per ml in prewarmed DMEM containing 2% FCS, 1 mM Hepes, 
penicillin, streptomycin, and 5 ~g per ml Hoechst 33342 (Sigma 
Chemical Co., St. Louis, MO) and were incubated for 90 rain at 
37~  When verapamil was used, bone marrow was stained as de- 
scribed in the  presence  of 50  ~M  verapamil  (Sigma  Chemical 
Co.). The resolution of the various Hoechst populations is highly 
sensitive to the staining time and the Hoechst dye concentration 
(10). After Hoechst staining, cells were pelleted and maintained at 
4~  before antibody staining or FACS  |  analysis (Becton Dickin- 
son & Co., Mountain View, CA). For antibody staining, Hoechst- 
stained  bone  marrow  was  suspended  in  HBSS  containing 2% 
FCS, 1 mM Hepes, penicillin, and streptomycin (HBSS+) at 108 
cells  per nil. The antibodies were  added at  1/50 to  1/100 dilu- 
tions. The lineage cocktail used was comprised of the following: 
CD4  (GK1.5, Becton Dickinson &  Co.);  CD8  (53-6.7, Becton 
Dickinson &  Co.); CD5  (53-7.3; PharMingen, San Diego, CA); 
B220 (RA3-6B2; Caltag Laboratories, South San Francisco, CA); 
Mac-1  (M1/70.15,  Caltag Laboratories);  and Gr-1  (P,  B6-8C5, 
PharMingen). The mixture was incubated on ice for 10 rain, the 
bone marrow was then washed once in excess  HBSS+  and the 
cells  were  pelleted  through  a  serum cushion.  All washes  were 
performed in this manner. The cells were resuspended in media 
containing goat anti-rat antibody conjugated to PE (mouse serum 
adsorbed; Caltag Laboratories), and incubated for 10 rain on ice. 
After washing, the cells  were resuspended in 1/3 volume rat se- 
rum  (Cappel Laboratories,  Cochranville, PA)  and 2/3  HBSS+. 
After 10 rain on ice, biotinylated Sca-1 antibody (E13 161-7) was 
added  for  10  rain on ice.  After washing, the  cells  were  stained 
with avidin-FITC (Becton Dickinson & Co.) for 10 rain on ice. 
After the final wash, the bone marrow cells were filtered through 
a 70-/.LM nylon filter (Falcon Plastics,  Cockeysville, MD) and re- 
suspended in HBSS +  containing 2 ~g/ml propidium iodide (PI). 
For sorting experiments, the bone marrow was sometimes mag- 
netically preenriched for Sca-1 + cells using the MACS  |  (Miltenyi 
Biotec,  Sunnyvale, CA)  and  streptavidin  microbeads.  This  re- 
sulted in a 5-10-fold enrichment for Sca-1 + cells. 
Flow Cytometry.  Analysis and sorting were  performed  on  a 
dual-laser FACStar Plus  |  flow  cytometer  (Becton  Dickinson & 
Co.).  The  Hoechst dye was  excited at  350  nm and its fluores- 
cence was measured at two wavelengths using a 450 BP 20 (450/ 
20 nm band pass falter) and a 675 EFLP (675 nm long pass edge 
filter)  optical filter (Omega Optical Inc., Brattleboro, VT). A 610 
DMSP  (610 nm short pass dichroic mirror) was used to separate 
the  emission  wavelengths.  PI  fluorescence  was  also  measured 
through the 675 EFLP (having been excited at 350 nm). Hoechst 
"blue" represents the 450 BP filter, the  standard analysis  wave- 
length for Hoechst 33342 DNA content analysis.  Cells positive 
for  PI  were  seen  on  the  far  right  of the  Hoechst  "red"  (675 
EFLP) axis shown in Fig. 1 A, and excluded. The addition of PI 
did not affect the Hoechst staining profile, but allowed exclusion 
of dead cells. Both Hoechst blue and red fluorescence are shown 
on a linear scale.  The gating on forward and side scatter was not 
stringent; only erythrocytes and debris were excluded. Reanalysis 
of sorted  populations showed  purity  >98%.  Cells  were  sorted 
into glass  tubes  containing 100%  FCS,  and an  aliquot was  re- 
moved at the end of the sort and reanalyzed to establish high pu- 
rity.  The  side population (SP)  sorting gates  were  established as 
follows.  A  live gate  was  defined  on  the  flow  cytometer  using 
Hoechst  red  and blue axes  to  exclude dead  cells,  red  cells  (no 
Hoechst stain), and debris. After collecting 10  5 events within this 
live gate, the SP population was able to he clearly defined. A new 
gate was established on this population, as shown boxed in Fig.  l 
A. After the SP region was defined, this region was used as a live 
gate to display the Sca-1 + and lineage marker fluorescence of this 
subset of cells. The Sca-1 + lin~eg/l~ population stands out clearly 
with this gate.  A  sorting gate was then defined as cells  that fell 
into both of the regions boxed in Fig. 1, A and B. 
Transplantation.  Typically, bone marrow was  extracted from 
femurs and tibias of several male 6-10-wk-old C57BI/6-Ly-5.1 
mice, stained and purified as described above. Sorted cells  were 
washed, counted, and mixed (in competitive repopulation exper- 
iments)  with  unfractionated bone  marrow  obtained  from  two 
male 6-10-wk-old C57B1/6-Ly-5.2 mice, and the rnixtures were 
introduced into female C57B1/6-Ly-5.2 recipient mice (all from 
the Jackson Laboratory).  The recipients were  6--12-wk-old and 
were maintained on acidified water.  The recipients were irradi- 
ated with 1,100 rad given in two doses (620 and 480 rad) at least 
2 h apart. Bone marrow cells were given intravenously by retro- 
orbital injection under methoxyflurane anesthetic (Pittman Moore, 
Mundelein, IL).  All animal care was in accordance with institu- 
tional guidelines. 
Anall/sis.  Peripheral blood was taken from transplant recipi- 
ents by retro-orbital puncture under methoxyflurane anesthesia 
4 mo or more after transplant. Red blood cells were removed and 
the  nucleated peripheral blood cells  were  stained with biotiny- 
lated anti-Ly-5,  l  antibody that was detected with streptavidin-PE 
(Molecular Probes, Inc., Eugene, OR).  For lineage analysis,  the 
blood samples were subdivided and costained with directly con- 
jugated  lineage-specific antibodies against  Thy-1,  B220,  Gr-l, 
and/or Mac-1 (PharMingen). These blood samples were analyzed 
on the  FACStar Plus  |  or a  FACScan  |  flow cytometer  (Becton 
Dickinson & Co.). The anti-Ly-5.2 and anti-Ly-5.1 hybridomas 
used were  104.2.1  and A20.1.7, respectively (gifts from D.  Par- 
doll, Johns Hopkins University, Baltimore, MD). 
Separation of Go-Gift  ore S-G2  M  Stem Cells.  SP cells were pu- 
rified from 10 mice as described above. An aliquot of these ceils 
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Table 4, column 1. The rest of the sorted cells were incubated for 
60  min  in  DMEM  as  described  above,  containing  10  ~xg/ml 
Hoechst 33342  and 50  b~M verapamil. These were resuspended 
in HBSS including 2 Ixg/ml of PI, and sorted on the flow cytom- 
eter as described above. Several thousand cells were first allowed 
to  pass through  the  laser without  subfractionation.  These were 
transplanted as the "2￿  sorted" group. The remaining cells were 
sorted into 2n (G0-G1) or >2n  (S-G2M)  groups and transplanted 
accordingly. For PI analysis, stem cells purified as described above 
were pelleted by centrifugation and resuspended in 0.1% Na cit- 
rate, 50 Dg/ml PI. After incubation  on ice for 10 min, the cells 
were analyzed by standard flow cytometry procedures using 488- 
nm excitation. 
Results 
A  Distinct  Population of Hoechst 33342-stained  Cells  Is 
Sca- 1  + Lin  "~,r176  Hoechst 33342 is a fluorescent dye readily 
taken up by live cells where it binds to DNA. The quantity 
of Hoechst 33342 fluorescence in a cell is therefore an indi- 
cator of cell cycle as it relates to DNA  content.  However, 
when it was used to examine DNA  content in whole mu- 
rine  bone  marrow  by  standard  methods  (11),  a  complex 
fluorescence pattern was observed. When dye fluorescence 
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Figure  1.  Characterization  of Hoechst 33342  fluorescence on whole 
murine bone marrow. (.4) Hoechst fluorescence on whole normal bone 
marrow. The boxed region is the SP  region and represents 0.1%  of the 
total bone marrow. (B) Sca-1 + and lineage  marker profile of cells that fall 
exclusively  into the region indicated  in A. The percentage of cells that fall 
in the indicated  window is 75% in this example, and ranges from 75  to 
90% depending on precisely  where the gate in A is drawn. (C) Sca-1  and 
lineage  marker fluorescence on whole murine bone marrow. The indi- 
cated region is identical  to that in B and contains 1% of  the nucleated cells 
in the bone marrow. (D)  Hoechst fluorescence of the cells from whole 
bone marrow that  fall into  the  region indicated  in  C.  The  SP  region 
drawn is identical  to that in A, and 10% of the cells fall into this region. 
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was observed simultaneously  at two  emission wavelengths 
(red  and  blue),  several  distinct  populations  could  be  re- 
solved (Fig.  1 A). These populations appeared to represent 
multiple  cell  cycle  profiles  that  are shifted  relative  to  one 
another with regard to red and blue Hoechst fluorescence. 
In the course of our analysis ofhematopoietic cells in this 
staining  profile,  we  observed that  one  population  of cells, 
boxed in Fig.  1 A  (SP), was predominantly Sca-1 + lin  negn~ 
Fig.  1 B displays the Sca-1 + and lineage marker expression 
of the cells from whole bone marrow that fall into the re- 
gion boxed in Fig.  1 A. The region boxed in Fig.  1 B con- 
tains cells that express Ly-6A.2 (Sca-l+), and a low level of 
six  lineage  antigens  (detected  by  a  cocktail  of antibodies 
against  B220,  Gr-1,  Mac-l,  CD4,  CD5,  and  CD8)  and 
represents  75%  of the  cells  displayed.  These  cell  surface 
characteristics have previously been used to identify murine 
HSC  (12-14).  The SP population boxed in Fig.  1 A  repre- 
sents 0.1% of total bone marrow. Fig.  1 C shows that 1% of 
whole  unfractionated  bone  marrow  are  Sca-1 +  lin  neg/1~ 
cells when  using the  region  defined in  Fig.  1 B.  Fig.  1 D 
shows  that  SP  cells  comprise  a  subset  (~10%)  of this  1% 
fraction ofSca-1 + lin  "~g/l~  cells from whole bone marrow. 
Competitive Repopulation with SP Cells.  To  examine  the 
functional  properties  of the SP cells, long-term bone mar- 
row transplantation  experiments were performed. We used 
a competitive repopulation assay in which defined numbers 
of purified  cells  were  transplanted  into  lethally  irradiated 
recipients along with unfractionated but distinguishable whole 
bone  marrow  cells.  In  this  semiquantitative  method  (15, 
16),  the  relative stem cell activity of sorted vs. unfraction- 
ated  cells  was  assessed  by  determining  the  percentage  of 
peripheral  blood  cells derlved from each  of the  two  input 
populations  in  the  bone  marrow  transplant  recipients. 
These recipients were analyzed 4 mo after transplant when 
the majority of peripheral blood cells are derived from long- 
term reconstituting  stern cells introduced  in the  transplant 
instead of committed progenitors  (2).  In addition,  differen- 
tiated  cells and progenitors in the unfractionated  competi- 
tor bone marrow rescue recipients from the otherwise lethal 
irradiation.  This allows the long-term multilineage repopu- 
lating  functions  of the  input  HSC  to  be  examined  sepa- 
rately from  short-term  activities.  For  this  competitive  re- 
population assay, we used congenic C57B1/6  mouse strains 
that differ at the  Ly-5 locus  (17).  This antigen is found on 
the  surface  of all nucleated  peripheral  blood  cells  and  the 
two allelic variants are readily distinguished by specific mono- 
clonal  antibodies.  Thus  peripheral  blood  can  be  collected 
from  transplant  recipients  at  multiple  time  points  and  as- 
sayed  by  flow  cytometry  for  the  proportion  of the  two 
Ly-5 alleles present in each blood lineage. 
Data  from  two  competitive  repopulation  experiments 
with fractionated cells are shown in Table 1. In the first ex- 
ample, the following three populations  of cells were tested 
for stem cell activity: (a) SP cells;  (b) cells that fell distinctly 
outside of the SP region (NOT SP); and (c) cells that are part 
of the  SP  region,  but  would  be  contaminated  by non-SP 
cells  (Upper SP).  In  this  experiment,  in  order  to  provide 
large amounts of starting material, bone marrow cells were Table 1.  Competitive  Repopulation with Hoechst-purified SP Cells 
No. sorted  No. compet.  Mean percent 
Fraction  Ly-5.1 X  10 -3  Ly-5.2 X  10 -3  rt  Ly-5.1 PBL  SD  Enrichment 
% 
Experiment 1 
NOT SP  20  500  5  8  3  2 
Upper SP  8.2  500  5  3l  11  28 
SP  2  1,000  6  56  5  640 
SP  1  1,000  7  41  5  700 
SP  0.5  1,000  7  30  8  960 
Experiment2 
SP  1.0  200  5  79  11  720 
SP  0.3  200  4  54  14  780 
SP  0.1  200  4  43  3  1,500 
SP  1.0  400  4  52  2  430 
SP  0.3  400  3  26  9  470 
SP  0.1  400  5  29  15  1,600 
The first column displays the fraction of cells purified by flow cytometry (C57B1/6-Ly-5.1 derived). The second column displays the number of pu- 
rified cells transplanted. The third column displays the number of competitor cells introduced (C57B1/6-Ly-5.2 derived), n represents the number of 
transplant recipients at the time of analysis (usually the same as the number initially transplanted) in each group. The mean is the mean number of 
nucleated peripheral blood cells derived from the sorted population  (Ly-5.1+) present in recipients 4 mo after transplant. The enrichment is calcu- 
lated as the mean percent Ly-5. I + cells in the peripheral blood per purified cell introduced,  divided by the mean percent contribution  of Ly-5.2 + 
cells per unfractionated Ly-5.2 cell introduced. All numbers are rounded to two significant dints. 
preenriched  for  Sca-1 +  cells, which  have  been  shown  to 
mark all stem  cells in these mice and provide a  7-10-fold 
enrichment  for  HSC  activity  (13,  14,  18,  and  data  not 
shown).  Preenrichment  with  Sca-1 +  was  not  necessary, 
however, for obtaining the enrichments observed. As shown 
in  Table  1,  the  SP  fraction was  highly enriched for stem 
cell activity. In contrast, there is little detectable activity in 
the NOT  SP fraction and only a small amount of activity in 
the upper SP fraction. Numerous other competitive repop- 
ulation experiments with or without Sca-1  enrichment re- 
vealed almost no additional stem ceil activity outside of the 
SP  region  (data  not  shown).  In  the  second  experiment 
shown  in  Table  1,  three  doses  of SP  cells  were  tested 
against two doses of competitor cells. The SP cells gave rise 
to average enrichments of HSC activity of~l,000-fold  in 
these  and  other experiments.  Since  the  SP  cells represent 
0.1% of the total bone marrow,  these data are also consis- 
tent with the above finding that most if not all reconstitut- 
ing cells in  normal mouse  bone  marrow reside in  the  SP 
fraction. 
Radioprotection and Spleen CFU Content of SP Cells.  Hav- 
ing established by competitive repopulation that all stem cell 
activity fell into  the SP region, we investigated the ability 
of these  cells to  protect  recipients from  lethal irradiation 
(radioprotection). Varying doses  of purified SP  cells were 
transplanted into lethally irradiated recipients without com- 
petitor bone marrow. 4 mo after transplant, peripheral blood 
was collected and analyzed for donor (Ly-5.1) contribution. 
As shown by data from three separate experiments in Table 
2,  on  average,  ~150  purified cells radioprotected 50%  of 
recipients.  The  mean  contribution  of the  SP  cells to  he- 
matopoiesis in the peripheral blood of survivors was ~>81% 
except in one animal transplanted with 50 cells, where the 
PBL contribution was 12%. Radioprotection by whole un- 
fractionated bone marrow is also shown. Approximately 5  ￿ 
104  whole  bone  marrow  ceils  will  reproducibly protect 
"o50% of recipients from lethal irradiation. This constitutes 
an enrichment ofradioprotection activity of,-~300-fold. 
Day 12 spleen colony-forming activity, or CFU-s(12), of 
the  SP  cells was  also  measured.  In  three  separate  experi- 
ments,  we found an average of about  1 CFU-s(12) per 35 
SP cells injected (5.5  --+  1.7 per 200 cells injected, n  =  18; 
6.1  -+  1.6 per 200 cells, n  =  9; and 7.1  +  1.8 per 250 cells, 
n  =  11).  This  compares  with  1.3  CFU-s  (12)  per  104 
whole bone marrow cells (6.6  •  1.3 per 5  X  104  cells in- 
jected,  n  =  8).  These  data indicate that  CFU-s activity is 
enriched ~200-fold in the SP population. 
Multilineage Contribution by SP Cells.  The SP  cells were 
also  shown  to  contribute  to  both  lymphoid  and  myeloid 
lineages in the transplant recipients. Table 3 shows a lineage 
analysis 4 mo after transplant from the third experiment shown 
in  Table  2.  For each  group,  the  mean  percentage  of pe- 
ripheral blood cells with the given marker is indicated. It is 
evident that in all of the surviving recipients, there was a very 
consistent number of Thy-1, B220,  and Grl positive cells, 
indicating no  major hematopoietic anomalies in the trans- 
plant recipients. The percentage of each marker subset de- 
rived  from  the  purified  cells is  also  indicated.  Except  in 
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No. sorted  Mean percent 
Ly-5.1  n  Percent survival  Ly-5.1  PBL  SD 
Purified SP Cells  % 
Experiment 1 
Experiment 2 
Experiment 3 
Whole bone marrow (X 10 -3) 
25  10  0  0  - 
50  10  10  12  - 
100  20  25  81  11 
200  10  80  87  10 
500  10  70  89  6 
25  20  4  1  - 
50  19  0  0  - 
100  29  24  83  18 
200  20  60  89  6 
0  15  0  0  -- 
100  20  40  85  16 
250  20  45  95  4 
500  20  70  97  1 
1,000  19  68  97  1 
50  8  50  76  31 
100  9  88  92  4 
500  9  100  94  1 
1,000  10  100  94  1 
Results from three independent experiments are shown. The indicated numbers of purified HSC (male C57B1/6-Ly-5.1 derived, Hoechst SP, Sca-1 +, 
hnn~g/l~  cells were introduced into female C57B1/6-Ly-5.2 recipients as described in the legend to Table 1. The number of animals initially trans- 
planted in each group is shown in the second column (n). The percentage of animals surviving at least 4 mo after transplantation is shown in the third 
column. The mean percent SP cell-derived Ly-5.1 nucleated peripheral blood cells in the transplant recipients 4 mo after transplant is shown in col- 
umn four. All numbers are rounded to two significant digits. 
some of the animals surviving with only  100 purified cells, 
where  some host-derived contribution was  evident, all the 
hneages are overwhelmingly derived from the purified cells. 
Verapamil Blocks Formation of the SP region.  HSC  activity 
has been seen in Hoechst "low" staining regions before (see 
Discussion),  but  since we  had found  the  stem  cell activity 
in such a  specific staining region, we wondered  if it would 
be possible to account for the staining pattern.  It is known 
Table 3.  Lineage Analysis  of SP Cell Contribution 
Percent PBL with given marker  Percent of each marker that is 5.1 + 
No. SP  n  % 5.1  +  PBL  Thy-1  B220  Grl  Thyl  B220  Grl 
100  7  84.7  +  16.1  33.0  +  8.1  37.7 --+ 9.9  13.1  +  6.4  86.3  +  7.5  94.2 •  13.9  62.3  -+ 25.8 
250  9  94.7 -+ 3.5  27.3  •  8.2  37.1  -+ 6.7  14.5  •  3.5  85.9 •  4.0  99.0 +  1.9  78.8 •  6.3 
500  14  96.5 +  1.0  29.2 +  7.0  37.1  •  7.8  11.9  +  3.7  89.7  •  2.0  99.7 +  0.3  79.3 •  4.5 
1,000  13  97.0 •  0.7  23.4 •  4.6  40.7  +  7.3  11.5  -+ 4.3  88.9  •  1.9  99.8  •  0.2  81.0 •  4.3 
The analysis presented is from the third radioprotection experiment shown in Table 2. The number of transplanted SP cells is shown in column 1, 
with the number of recipients analyzed in column 2 (n). The mean percent SP-derived PBL is shown in the third column. The next three columns 
show the means of the proportion of cells in the peripheral blood displaying the indicated cell surface markers. These contain both donor and host- 
derived cells. The final 3 columns display the proportion of cells that display the indicated marker and also the Ly-5.1 marker, indicating that they are 
SP cell derived. 
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Figure 2.  Inhibition ofmdr activity with verapamil. (Arrows) SP region 
that contains the stern cells. (A) Whole bone marrow stained with Hoechst 
33342. (B) Whole bone marrow stained with Hoechst 33342 in the pres- 
ence of verapamil. 
that  several vital  dyes are  actively pumped  out  of cells by 
the  multidrug  resistance  protein  (mdr,  or p-glycoprotein), 
so we investigated the possibility that the low Hoechst flu- 
orescence was due to higher mdr activity in murine HSC. 
As shown in Fig.  2, the stem cell (SP) population was spe- 
cifically eliminated  when  bone  marrow  cells  were  stained 
with Hoechst 33342 in the presence of the drug verapamil, 
an inhibitor of mdr. Therefore, it is likely that the cells are 
uniquely low in Hoechst fluorescence because of mdr or a 
mdr-like-mediated efflux of the dye. 
Go-G1 and S-G2M Cells Contribute to Long-Term Reconsti- 
tution.  In whole  bone  marrow or in the  Sca-1 +  lin'eg/l~ 
cell populations,  the efflux of Hoechst dye prohibits its use 
as an indicator of cell cycle. However, we reasoned that the 
ability to specifically block the efflux of the dye in the pres- 
ence  of verapamil should  allow full uptake  of the  dye and 
appropriate  staining  of DNA.  This should  allow cell cycle 
analysis on live stem cells from either purified or heteroge- 
neous  populations  of hematopoietic  cells.  We  tested  this 
possibility on purified  SP  cells.  After obtaining  SP  cells as 
described above, we restained the sorted cells with Hoechst 
33342  in the presence  of verapamil.  Hoechst fluorescence 
in  SP  cells now  exhibited  a  typical cell cycle profile, with 
the number of cells in S-G2M between 1 and 3% of the pu- 
rified cells  (Fig.  3  A).  This figure correlates  well with  the 
number shown to be in S-G2M by PI staining of the puri- 
fied cells  (Fig.  3  B).  This number is much lower than  the 
A 
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Figure 3.  Analysis  of the cell cycle status of purified HSC. (A) Purified 
HSC restained with Hoechst 33342 in the presence ofverapamil. (B) Pu- 
rified HSC stained with PI. 
fraction  of cells  in  S-G2M  in  whole  bone  marrow  (20%, 
data  not  shown),  and  in  other  populations  enriched  for 
stem  cells  (19).  Our  data,  therefore,  support  the  widely 
held view that HSC from normal bone marrow are largely 
quiescent  (20). 
The ability to isolate viable, replicating stem cells made it 
possible to determine whether the ceils were capable of re- 
constituting lethally irradiated recipients and, if so, to com- 
pare their  engraftment properties  with  cells in  G0-G 1.  For 
these  studies,  the  two  subsets  of the  SP  population  were 
purified by flow cytometry,  and  tested  in  the  competitive 
repopulation  assay. Table 4  shows  data from one such  ex- 
periment. The 1￿  sorted population represents transplanta- 
tion of an aliquot of cells that have been purified once, and 
serves as a control for comparison with enrichment activity 
obtained  in  other experiments.  The  2￿  sorted population 
represents SP cells that have been restained with Hoechst in 
the  presence  of verapamil,  and  run  through  the  flow  cy- 
tometer without  subfractionation.  A  large discrepancy be- 
tween the activity of the  1 ￿  and 2 ￿  sorted samples would 
have indicated possible damage to the stem cells incurred in 
the second staining or sorting procedure.  In fact, the activ- 
ity of the  1￿  and 2￿  sorted populations  was very similar. 
We found that the  contribution  of the  G0-G~ HSC  to the 
peripheral blood was almost identical to that of the S-G2M 
HSC,  and both populations  were virtually identical  in  ac- 
tivity to HSC  that have not been subfractionated  (1 ￿  and 
2￿  sorted HSC).  The percentage  of peripheral blood cells 
derived from the sorted  cells was almost identical  at 2  and 
11  mo,  indicating  the  long-term  engraftment  capacity  of 
both populations of cells. 
Discussion 
The above studies describe the development of a method 
for the  enrichment  of murine  HSC  that involves  a  novel 
use  of the  vital  dye  Hoechst  33342  and  the  use  of the 
method  to  isolate  both  quiescent  and  replicating  popula- 
tions of stem cells. The Hoechst-purified SP cell population 
described above comprises 0.1% of the bone marrow and is 
highly  homogeneous  with  respect  to  cell  surface  markers 
found on murine HSC  (12-14).  Furthermore,  the ceils are 
enriched  ~'-,1,000  fold for HSC  activity,  as  determined  in 
competitive  repopulation  experiments,  and  provide  high 
long-term multilineage contribution  in radioprotection  ex- 
periments. 
Numerous  strategies  for the  enrichment  or purification 
of HSC  have  been  described  previously  (11,  12,  21-24). 
However,  the  Hoechst  SP  region  is  the  first  use,  to  our 
knowledge,  of a  single  dye  or  manipulation  to  define  a 
population with HSC activity that is so strikingly small and 
homogeneous.  Further,  the  SP  region  is highly  reproduc- 
ible and easily identifiable,  and therefore should be able to 
be  used  advantageously  by many  experimenters.  In  addi- 
tion, the SP region can be used to allow independent  veri- 
fication of cell surface characteristics,  as shown in Fig.  1 B. 
Although we have demonstrated a high level of stem cell 
activity in  the  competitive  repopulation  assay, we  do  not 
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No. sorted  No. compet.  Mean percent 
Group  Ly-5.1  Ly-5.2 cells X 10 -3  Ly-5.1 PBL  SD  Enrichment 
At 2 mo 
At 11 mo 
% 
1 ￿  sorted  400  400  9  44  10  800 
2￿  sorted  400  400  7  56  6  1,300 
2￿  sorted  200  200  6  52  16  1,100 
Go-G  1  400  400  6  47  9  870 
Go-G  ~  200  200  7  62  17  1,600 
S-G2M  200  200  5  64  2  1,800 
1 ￿  sorted  400  400  7  51  14  1,000 
2X sorted  400  400  6  60  8  1,500 
2X sorted  200  200  6  56  26  1,300 
Go-G~  400  400  6  54  7  1,200 
G0-G1  200  200  7  60  11  1,500 
S-G2M  200  200  5  63  20  1,700 
One experiment is shown with the analysis performed at both 2 and 11 mo after transplant. The number of purified or subfractionated SP cells 
(Ly-5.1  +) transplanted per mouse is shown in the second column. The number ofunfractionated Ly-5.2 competitor bone marrow cells cotransplanted 
is indicated in the third column, and the number of  mice at the time of  analysis (n) in the fourth column. The mean shown is the mean percentage of 
Ly-5.1  + nucleated peripheral blood cells at the time after transplant indicated. The enrichment is calculated as in Table 1. All numbers are rounded to 
two significant digits. 
observe  substantial  radioprotection  with  very small  num- 
bers of cells as has been described with other populations of 
purified cells  (12,  14, 25, 26).  This could be interpreted  to 
reflect a lower level of purity of our stem cell population 
than  others,  differences in animal husbandry practice,  or a 
lack of inherent radioprotective activity in SP cells,  a func- 
tion that may be very different from long-term reconstitu- 
tion.  Although the SP cells  do not exhibit radioprotective 
activity at small cell doses, they do show very high levels of 
contribution in almost all of the animals that are rescued. In 
contrast, Spangrude and Scolly (26)  report "30% radiopro- 
tection with  20-33 purified  Sca-1 + lin'eg/l~  cells,  but the 
donor contribution in the rescued animals remains very low 
(3%)  until  larger numbers  of purified  cells  are  introduced 
(1,000  cells were reported to give an average of 98% con- 
tribution).  Since  SP  cells  appear  to be  a  subset  of Sca-1 + 
lin  ~g/l~  cells,  these results indicate that the Hoechst purifi- 
cation strategy may allow at least partial separation of radio- 
protection activity from long-term reconstitution activity. 
In support of this notion, we have compared SP cell ra- 
dioprotection  activity  with  that  of whole  bone  marrow. 
On average, we see about 150 SP cells conferring radiopro- 
tection  to  50%  of lethally  irradiated  transplant  recipients. 
This  compares  with  5  ￿  10  4  whole  bone  marrow  cells 
conferring  50%  radioprotection  in  the  same  conditions 
(Table  2).  This  is  an  enrichment  of 50%  radioprotection 
activity of ~300-fold. Furthermore,  we observe the CFU-s 
(12)  activity to be ~1  per 35  SP cells injected.  Compared 
with the CFU-s (12) content of whole unfractionated bone 
marrow ("-'1.3 in  104 injected  cells),  this represents  an en- 
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richment for CFU-s (12) of only "~200-fold. Since we ob- 
serve  an  enrichment  of long-term  stern  cell  activity  of 
,'~l,000-fold,  this indicates  that although there is some ra- 
dioprotection activity, and some CFU-s (12) in the SP re- 
gion, the majority of cells with these functions do not ap- 
pear  to  be  present  in  this  population,  even  though  the 
majority of long-term reconstitution activity is present. 
Previous  observations  of HSC  activity being  associated 
with  a  low  level  of Hoechst  dye  have  been  made  using 
solely the  Hoechst blue  wavelength  in  combination  with 
other  sorting parameters  (11,  27-29).  However,  the  dual 
wavelength analysis described here allows an exquisite sep- 
aration  of multiple  populations,  and  clear identification  of 
the discrete SP region that is enriched for stem cell activity 
at  least  10-fold  higher  than  what  had  previously  been 
achieved using Hoechst 33342.  It is possible that using the 
Hoechst  red  wavelength  alone,  the  SP  region  could  be 
identified. 
The  observation  that  cells  stained  with  Hoechst  33342 
can show distinct patterns  of fluorescence when examined 
at  different  wavelengths  had  been made  previously,  using 
cell lines and thymus tissue  (10, 30).  In those studies,  as in 
our own, the fluorescence patterns were shown to be depen- 
dent on both the Hoechst concentration and staining times. 
These findings may be interpreted to reflect, at least in part, 
the existence of different binding states of the Hoechst dye 
that occur as a consequence of different chromatin confor- 
mations,  and  that  result  in  different  fluorescence  spectra 
from the bound dye. This would potentially give rise to a 
unique  Hoechst  "fingerprint"  for different  cell  types  that would reflect the whole set of binding states in a given cell 
type.  In  addition  to  the  two  to  three  major populations 
seen in  Fig.  1 A, we have observed other minor popula- 
tions with unique  states of red and blue Hoechst fluores- 
cence  when  the  major  populations  have  been  removed 
(data  not  shown).  Whereas  this phenomena may account 
for the distribution of the major bone marrow populations 
accross the two emission wavelengths as seen in Fig. 1 A, it 
does  not  explain  the  uniquely  low  Hoechst  fluorescence 
exhibited by the SP ceils (see below). 
The fact that the SP region was so well separated from 
the rest of the bone marrow cells suggested either that the 
Hoechst dye was inefficiently taken up by stern cells, or that 
it was being actively pumped out of the cells. The verapamil- 
blocking experiment shown in Fig. 2 suggests that it is the 
efficiency of efflux of the dye that accounts for the uniquely 
low fluorescence of the SP population. Although verapamil 
has very broad activities, it is known to inhibit p-glycopro- 
tein. Therefore, this very high dye efflux activity which can 
be blocked with verapamil may be due to a higher level of 
p-glycoprotein on the surface of HSC, a higher level of ac- 
tivity of the p-glycoprotein present, or a mdr-like activity 
not yet identified.  Antibody  studies  on the  expression of 
the  product of the  MDRI  gene in human hematopoietic 
cells  suggest that p-glycoprotein is in fact expressed quite 
widely, and that ~65% of bone marrow cells may express 
mdr (31,  32). If this is also true in the mouse, then mdr ex- 
pression alone  may not  account  for the  unique  Hoechst- 
staining properties of SP cells. In light of this, a purification 
strategy based on functional properties, such as the one we 
have developed, will likely be more powerful than a scheme 
based on the level of mdr cell surface expression (e.g., anti- 
body based). 
R.hodamine-123 (Rh123) is another fluorescent vital dye 
that has been used to enrich for HSC in combination with 
other antibody-based approaches (24,  33-35). Like the low 
Hoechst 33342  staining of HSC,  cells  that stain with low 
levels of Rh123  contain the most primitive hematopoietic 
cells. Although this may be an indicator of low mitochon- 
drial activity (and hence quiescence), R.h123 is also known 
to be a substrate for mdr (31).  It is possible that the utility 
of both R.h123  and Hoechst 33342 is based on their mdr- 
mediated effiux from stem cells. Although powerfully used 
in combination with other approaches, Rh123 alone is not a 
useful  tool for HSC  purification,  as  the  stained  stem cell 
population is not distinct from the rest of the bone marrow 
as is the case with the Hoechst SP. It is possible that Hoechst 
33342 is an exceptionally good or specific substrate for mdr, 
allowing superior resolution of cells with extremely high mdr 
activity over those with simply high mdr activity. If this is 
indeed the case, other fluorescent non-DNA-binding sub- 
strates for mdr may be able to be identified that allow an 
equally powerful purification. The P,,h123 l~  subset shown 
to contain the most primitive stem cells has been defined as 
the 10% ofSca-1 + ]in  neg/l~  Thy-l.1 l~  ceils that contain the 
lowest amount of Rh123  after staining  (33,  34).  Hoechst 
SP cells also comprise a 10% subset ofSca-1 + lin  neg/l~  cells. 
The 12-d spleen colony formation of the SP population is 
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~1  CFU-s(12)  per  35  purified  cells  injected.  This  fre- 
quency  correlates  extremely  well  with  the  CFU-s(12) 
forming frequency of the P,  h123  l~  subpopulation of Sca- 
1 + linneg/l~  Thy-l.1 l~  cells  (7,  33). We suspect that these 
populations will prove to be very similar. 
Although self-renewal is a property traditionally  associ- 
ated with HSC  (20),  the ability of stem cells to proliferate 
without concomitant differentiation has not been formally 
demonstrated. The ability to block Hoechst effiux in SP ceils 
with verapamil allowed us to examine DNA content with 
Hoechst 33342 and thereby physicially isolate live stem cells 
that had undergone  or were undergoing DNA replication 
and mitosis. As shown in Fig. 3, purified SP cells restained 
with Hoechst in the presence ofverapamil exhibit a typical 
cell cycle profile, with N3% of the ceils in S-G2M. This is 
very similar to the percentage obtained with PI, and con- 
siderably lower than the number in S-G2M in whole bone 
marrow  (~20%).  This  supports  the  notion  that  HSC  are 
largely quiescent.  Our long-term reconstitution studies in- 
volving S-G2M  and  G0-G  1 fractions  of stem cells  clearly 
show that both fractions are equally competent for recon- 
stitution.  These results strongly suggest that entry of stem 
ceils into cycle does not necessarily lead to an absolute loss 
of self-renewal or reconstitutive  activity. Whether  or not 
the S-G2M fraction of cells isolated by our procedure rep- 
resents cells  that are  continuously  in  cycle or simply cells 
that are captured in a rare state of replication remains to be 
determined.  It  will  be  interesting  to  determine  whether 
quiescent  and  dividing  stem  cells  from normal  mice  will 
possess  distinct functional properties as revealed by specific 
assays such  as  secondary  transplantation  or  growth  factor 
responsiveness. 
It is noteworthy that Fleming et al.  (25)  also  compared 
the reconstitution potential of G0-G~  and S-G2M fractions 
of Sca-1 + lin  neg/l~  Thyl.l l~  stem cells from normal mice, 
using Hoechst 33342  staining in the absence of verapamil. 
In contrast to our results, they observed 18% of the cells to 
be in S-G2M, and reported a lower reconstitution capacity 
of this subset of cells  relative to G0-G  1 cells.  However, as 
shown above, Hoechst fluorescence in HSC is dramatically 
influenced by mdr-like efflux activity, unless the effiux ac- 
tivity is blocked with inhibitors such as verapamil. Conse- 
quently,  the  Hoechst  content  of the  HSC  analyzed  by 
Fleming et al.  (25) would be lower than expected and it is 
likely that a significant proportion of cycling HSC would 
be found in the  G0-G1  peak of their staining profile  (and 
perhaps below it).  Therefore,  the  reconstitution  potential 
of the cycling fraction was probably underestimated. 
In summary, we have developed a novel approach to the 
enrichment ofmurine HSC. The stem ceil activity has been 
defined solely on the basis  of its ability to contribute to all 
peripheral  blood lineages  in  long-term  bone  marrow re- 
constitution of lethally irradiated recipients. The dye-based 
fractionation allows independent  determination  of the cell 
surface characteristics of HSC, a feature of the purification 
method  that  may be particularly  useful for characterizing 
the surface phenotype of stern cells from other species (see 
below). We have also shown that this purification strategy 
Cells Replicating In Vivo may rely on a high level of mdr-like activity present in stem 
cells.  This finding allowed us to establish a strategy for sep- 
arating cycling from quiescent stern cells,  to show that cy- 
cling cells capable of the long-term engraftment of lethally 
irradiated  recipients  exist  (and  can be  physically isolated), 
and to show that their reconstituting capacities are equiva- 
lent to those of quiescent stem cells. 
The stem cell purification strategy described above may 
be able  to be  extended  to other species.  In particular,  we 
have stained human adult bone marrow,  human umbilical 
cord blood, and porcine bone marrow with Hoechst 33342 
and  observe  a  staining  pattern  remarkably  similar  to  that 
which we observe with routine cells (data not shown). We 
are  currently  characterizing  stained  SP  cells  from human 
bone marrow with respect to cell surface markers found on 
human progenitor cells  (36-39)  and in in vitro culture  as- 
says.  It  will  be  of  considerable  interest  to  determine 
whether  the  same  markers  defined  through studies  of the 
progenitor activities of human cells  are present on cells pu- 
rified by our method, and whether the replicating cells iso- 
lated by our methods may show responses to hematopoietic 
growth factors distinct from those observed with quiescent 
stern cell populations. 
The  ability  to  obtain  populations  of cycling stem  cells 
may also ultimately  have  important  implications  for HSC 
gene  therapy.  Previous  attempts  to  infect  unmanipulated 
murine  and  human  HSC  with  recombinant  retroviruses 
have  met  with  mixed  success,  presumably  at  least  in part 
because  the  inability  of retroviral  vectors  to  integrate  in 
quiescent cells.  As shown here,  only 1-3%  of HSC are in 
cycle. The use of the rare population of stem cells  that are 
naturally replicating in vivo as targets for gene transfer may 
provide  an important  alternative  to transduction  strategies 
based on attempts to influence the cell cycle status of stem 
cells.  Studies to test this possibility are in progress. 
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